Suzhou Basecare Medical Corporation Limited (2170.HK)

HKD 2.75

(-8.94%)

EBITDA Summary of Suzhou Basecare Medical Corporation Limited

  • Suzhou Basecare Medical Corporation Limited's latest annual EBITDA in 2023 was -174.14 Million CNY , down -41.36% from previous year.
  • Suzhou Basecare Medical Corporation Limited's latest quarterly EBITDA in 2023 FY was N/A , down -41.36% from previous quarter.
  • Suzhou Basecare Medical Corporation Limited reported an annual EBITDA of -117.73 Million CNY in 2022, up 0.32% from previous year.
  • Suzhou Basecare Medical Corporation Limited reported an annual EBITDA of -118.88 Million CNY in 2021, down -155.16% from previous year.
  • Suzhou Basecare Medical Corporation Limited reported a quarterly EBITDA of -138.3 Million HKD for 2023 Q4, down 0.0% from previous quarter.
  • Suzhou Basecare Medical Corporation Limited reported a quarterly EBITDA of N/A for 2023 FY, down -41.36% from previous quarter.

Annual EBITDA Chart of Suzhou Basecare Medical Corporation Limited (2023 - 2018)

Historical Annual EBITDA of Suzhou Basecare Medical Corporation Limited (2023 - 2018)

Year EBITDA EBITDA Growth
2023 -174.14 Million CNY -41.36%
2022 -117.73 Million CNY 0.32%
2021 -118.88 Million CNY -155.16%
2020 -873.32 Million CNY -3459.89%
2019 -520.88 Million CNY 97.03%
2018 -148.01 Million CNY 0.0%

Peer EBITDA Comparison of Suzhou Basecare Medical Corporation Limited

Name EBITDA EBITDA Difference
Vincent Medical Holdings Limited 104.43 Million HKD 266.752%